Purple Biotech Ltd (PPBT) Directors and Executive Officers - CSIMarket
CSIMarket
 
Purple Biotech Ltd  (NASDAQ: PPBT)

Purple Biotech Ltd

Officers & Directors


Eric Rowinsky, M.D., age 69, serves as an Independent Director and Chairman of the Board. He has extensive experience in cancer therapeutics development and registration, having held consulting roles as Chief Medical Officer (CMO), Chief Scientific Officer (CSO), and advisor to various biopharmaceutical companies. Currently, he is the CMO for RRD International and has held leadership positions at Hummingbird Biotherapeutics, Biocity, Innovative Cellular Therapeutics, Inspira, Inc., Stemline Therapeutics, Inc., Primrose Therapeutics, Inc., and ImClone Systems Inc. He has also held academic positions and served on multiple public company boards. Gil Efron, CPA, MA, age 60, is Director and Chief Executive Officer. Shai Lankry, age 49, is Chief Financial Officer. Hadas Reuveni, Ph.D., age 58, is Vice President of Research and Development. Michael Schickler, Ph.D., age 67, is Head of Clinical and Regulatory Affairs.

Purple Biotech Ltd currently has 4 employees.






PPBT Management Effectiveness PPBT Revenue per Employee PPBT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.